INS and metabolic dysfunction-associated steatohepatitis: Further studies at the NIH and other treatment centers showed that metreleptin decreased hyperphagia (17), improved insulin sensitivity (91, 92), reduced liver steatosis and improved NASH score on biopsy specimens (30, 93).